Marker Therapeutics (MRKR) Treasury Shares (2011)

Marker Therapeutics (MRKR) posted quarterly Treasury Shares of $1.0 million for Q4 2011, up 76.82% quarter-over-quarter from $586858.0 in Q2 2011.

Marker Therapeutics (MRKR) Treasury Shares (2011) Analysis & Trends

Marker Therapeutics (MRKR) has reported Treasury Shares for 1 consecutive years, with $1.0 million the latest figure, recorded in Q4 2011.

In Q4 2011, Treasury Shares changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2011 stood at $1.0 million (changed N/A YoY), while the FY2011 annual figure was $1.0 million, changed N/A from the prior year.
Treasury Shares advanced to $1.0 million in Q4 2011 per MRKR's latest filing, from $586858.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.0 million in Q4 2011 and bottomed at $586858.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Marker Therapeutics	27.04 Mn	15.11 Mn	-	-

Download Data